ATEK vs. CRTX, OMCL, HSTM, MDRX, SPMC, RRAC, BACQ, CDRO, HOND, and VACH
Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Sound Point Meridian Capital (SPMC), Rigel Resource Acquisition (RRAC), Bleichroeder Acquisition Corp I - Class A (BACQ), Codere Online Luxembourg (CDRO), HCM II Acquisition (HOND), and Voyager Acquisition (VACH).
Athena Technology Acquisition vs. Its Competitors
Cortexyme (NASDAQ:CRTX) and Athena Technology Acquisition (NYSE:ATEK) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations.
Cortexyme has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Athena Technology Acquisition has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500.
In the previous week, Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the news media.
63.2% of Cortexyme shares are held by institutional investors. Comparatively, 17.3% of Athena Technology Acquisition shares are held by institutional investors. 27.9% of Cortexyme shares are held by company insiders. Comparatively, 88.4% of Athena Technology Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.
Athena Technology Acquisition received 478 more outperform votes than Cortexyme when rated by MarketBeat users. However, 64.44% of users gave Cortexyme an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote.
Summary
Athena Technology Acquisition beats Cortexyme on 5 of the 8 factors compared between the two stocks.
Get Athena Technology Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Athena Technology Acquisition Competitors List
Related Companies and Tools
This page (NYSE:ATEK) was last updated on 6/15/2025 by MarketBeat.com Staff
Buy ATEK Stock Free ATEK Stock Alerts